BE903065A - Nouvelles preparations pharmaceutiques - Google Patents

Nouvelles preparations pharmaceutiques

Info

Publication number
BE903065A
BE903065A BE1/011316A BE1011316A BE903065A BE 903065 A BE903065 A BE 903065A BE 1/011316 A BE1/011316 A BE 1/011316A BE 1011316 A BE1011316 A BE 1011316A BE 903065 A BE903065 A BE 903065A
Authority
BE
Belgium
Prior art keywords
pharmaceutical preparations
new pharmaceutical
formula
ketotifen
xanthine
Prior art date
Application number
BE1/011316A
Other languages
English (en)
French (fr)
Original Assignee
Sandoz Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sandoz Sa filed Critical Sandoz Sa
Publication of BE903065A publication Critical patent/BE903065A/fr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A61K31/52—Purines, e.g. adenine

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
BE1/011316A 1984-08-16 1985-08-14 Nouvelles preparations pharmaceutiques BE903065A (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CH392784 1984-08-16
CH438784 1984-09-14

Publications (1)

Publication Number Publication Date
BE903065A true BE903065A (fr) 1986-02-14

Family

ID=25694194

Family Applications (1)

Application Number Title Priority Date Filing Date
BE1/011316A BE903065A (fr) 1984-08-16 1985-08-14 Nouvelles preparations pharmaceutiques

Country Status (15)

Country Link
AU (1) AU4617185A (sv)
BE (1) BE903065A (sv)
DE (1) DE3528481A1 (sv)
DK (1) DK370085A (sv)
FR (1) FR2569109A1 (sv)
GB (1) GB2163957A (sv)
GR (1) GR851988B (sv)
HU (1) HUT40568A (sv)
IL (1) IL76089A0 (sv)
IT (1) IT1200102B (sv)
LU (1) LU86044A1 (sv)
NL (1) NL8502178A (sv)
PT (1) PT80961B (sv)
SE (1) SE8503771L (sv)
WO (1) WO1986001108A1 (sv)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL8701335A (nl) * 1986-06-21 1988-01-18 Sandoz Ag Orale farmaceutische preparaten.
GB2284761A (en) * 1993-12-03 1995-06-21 Euro Celtique Sa Prophylactic treatment of asthma
US8282955B2 (en) 2001-10-15 2012-10-09 Ferring B.V. Method for the preparation of a pharmaceutical composition comprising 5-aminosalicylic acid for use in treatment of ulcerative colitis and Crohn's disease
US20060083714A1 (en) * 2003-01-27 2006-04-20 Warner James M Combination of a pde iv inhibitor and a tnf-alpha antagonist
EP1615619A2 (en) 2003-04-23 2006-01-18 Ferring B.V. Sachet for a pharmaceutical composition
EP1547601A1 (en) * 2003-12-23 2005-06-29 Ferring B.V. Coating method
CN106913572B (zh) * 2017-04-06 2019-09-20 地奥集团成都药业股份有限公司 一种复方茶酮缓释片及其制备方法

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS51142543A (en) * 1975-05-20 1976-12-08 Sandoz Ag Improvement in organic compound

Also Published As

Publication number Publication date
NL8502178A (nl) 1986-03-17
IT8548441A0 (it) 1985-08-02
GR851988B (sv) 1985-12-10
DE3528481A1 (de) 1986-02-27
DK370085A (da) 1986-02-17
IT1200102B (it) 1989-01-05
SE8503771L (sv) 1986-02-17
SE8503771D0 (sv) 1985-08-12
HUT40568A (en) 1987-01-28
AU4617185A (en) 1986-02-20
FR2569109A1 (fr) 1986-02-21
GB8520189D0 (en) 1985-09-18
PT80961A (en) 1985-09-01
GB2163957A (en) 1986-03-12
WO1986001108A1 (fr) 1986-02-27
DK370085D0 (da) 1985-08-14
PT80961B (en) 1987-07-13
IL76089A0 (en) 1985-12-31
LU86044A1 (fr) 1986-02-18

Similar Documents

Publication Publication Date Title
PT84840A (en) Novel styryl pyrazoles isoxazoles and analogs thereof having activity as 5-lipoxygenase inhibitors pharmaceutical compositions and methods of use
OA08617A (fr) Inhibiteurs de métalloendopeptidase neutre dans le traitement de l'hypertention.
FI905531A0 (fi) Transdermalisk anvaendning av 2-amino-6-n-propylamino-4,5,6,7-tetrahydrobensotiazol.
FR2615394B1 (fr) Utilisation de certains 17-cetosteroides, eventuellement avec un immunomodulateur et/ou un agent antiviral, pour fabriquer un medicament pour le traitement et la prevention des infections retrovirales
DK209088D0 (da) Medicinpraeparater, deres fremstilling og anvendelse
ATE184792T1 (de) 2-bromomelatonin zur behandlung von schlafstörungen
HUP0001293A1 (hu) Heterociklusos vegyületek és ezeket tartalmazó gyógyászati készítmények béta-amiloid-peptidek gátlására
FR2608045B1 (fr) Utilisation d'inhibiteurs de xanthine- oxydase, de piegeurs de radicaux libres oxygenes et de chelateurs du fer pour la fabrication d'une composition pharmaceutique destinee au traitement du glaucome et compositions pharmaceutiques destinees au traitement du glaucome
FR2711140B1 (fr) 1-Naphtylpyrazole-3-carboxamides substitués actifs sur la neurotensine, leur préparation, les compositions pharmaceutiques en contenant.
ATE83376T1 (de) Chinolinylaether tetrazole als mittel zur behandlung von hyperempfindlichen krankheiten.
BE903065A (fr) Nouvelles preparations pharmaceutiques
EP0305277A3 (fr) Application de l'amino-2 trifluoro-méthoxy-6 benzothiazole pour obtenir un médicament destiné au traitement des troubles du sommeil et de la dépression
FR2525901B1 (fr) Agent de prophylaxie et de traitement des anomalies des lipides sanguins et/ou de l'arteriosclerose, a base d'une enzyme proteolytique
ATE75399T1 (de) Therapeutikum zur behandlung von magengeschwueren.
FR2654931B1 (fr) Compositions pharmaceutiques possedant une activite sur l'ataxie et les troubles de l'equilibre, cerebelleux ou autres, de toutes origines, comprenant l'association de l-5-hydroxytryptophane et de carbidopa.
FR2656523B1 (fr) Compositions pour l'usage cosmetique et/ou dermatologique, comprenant des pidolates metalliques.
FR2672888B1 (fr) Nouvelles urees et thiourees, leur preparation et leur application en therapeutique.
BE892339A (fr) Agents pour le traitement d'affections cardiaques coronariennes
FR2666228B1 (fr) Composition pour le traitement des surcharges ponderales et/ou de la cellulite.
FR2426460A1 (fr) Composition antiallergique
OA08609A (fr) Composition pharmaceutique pour le traitement des infections bactériennes.
FR2370053A1 (fr) Acides 7-acylamino-3-(1-(2,3-dihydroxypropyl)tetrazole-5-ylthiomethyl)-3-cepheme-4-carboxyliques et leur application en therapeutique
BE904146A (fr) Compositions pharmaceutiques a base de 3-aminopropoxyindoles.
SE8802323D0 (sv) 8alfa-acylaminoergoline, its preparation and pharmaceutical compositions containing it
BE881763A (fr) Nouvelles compositions pharmaceutiques utilisables pour le traitement de l'hypertension

Legal Events

Date Code Title Description
RE Patent lapsed

Owner name: S.A. SANDOZ

Effective date: 19880831